share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Apr 4 10:40
Summary by Moomoo AI
Recursion Pharmaceuticals, Inc. officer and director, Gibson Christopher, is set to sell 25,000 Class A shares on 04/04/2024, with an aggregate market value of $225,500. The shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This upcoming sale follows a series of transactions over the past three months, where a total of 239,591 shares were sold for gross proceeds of approximately $2.4 million.
Recursion Pharmaceuticals, Inc. officer and director, Gibson Christopher, is set to sell 25,000 Class A shares on 04/04/2024, with an aggregate market value of $225,500. The shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This upcoming sale follows a series of transactions over the past three months, where a total of 239,591 shares were sold for gross proceeds of approximately $2.4 million.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more